Anne Catherine Bretz

636 total citations
15 papers, 479 citations indexed

About

Anne Catherine Bretz is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Anne Catherine Bretz has authored 15 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 2 papers in Dermatology. Recurrent topics in Anne Catherine Bretz's work include Cancer-related Molecular Pathways (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Epigenetics and DNA Methylation (4 papers). Anne Catherine Bretz is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Epigenetics and DNA Methylation (4 papers). Anne Catherine Bretz collaborates with scholars based in Germany, United States and Finland. Anne Catherine Bretz's co-authors include Thorsten Stiewe, Joël P. Charles, Rasa Beinoravičiūtė-Kellner, Markus Sauer, Andreas Rosenwald, Katharina Schlereth, Michaela Beitzinger, Małgorzata Burek, Elisabeth Mack and Marco Mernberger and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Molecular Cell.

In The Last Decade

Anne Catherine Bretz

14 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Catherine Bretz Germany 10 356 298 74 45 41 15 479
Hubert Fleury Canada 11 224 0.6× 179 0.6× 48 0.6× 16 0.4× 69 1.7× 13 390
Joseph A. Wawrzyniak United States 9 351 1.0× 119 0.4× 71 1.0× 18 0.4× 32 0.8× 9 494
Marco Barazas Netherlands 6 270 0.8× 213 0.7× 47 0.6× 11 0.2× 21 0.5× 7 361
Kevin T. Nash United States 8 251 0.7× 242 0.8× 60 0.8× 19 0.4× 35 0.9× 14 466
Joy Hendley Australia 8 339 1.0× 313 1.1× 75 1.0× 13 0.3× 32 0.8× 9 466
Jean‐Claude Ehrhart France 11 364 1.0× 194 0.7× 79 1.1× 39 0.9× 35 0.9× 20 503
Miha Pavšič Slovenia 13 281 0.8× 181 0.6× 68 0.9× 35 0.8× 51 1.2× 29 484
Silke E. Lindner Austria 7 213 0.6× 179 0.6× 60 0.8× 13 0.3× 80 2.0× 9 341
Lynn Meister United States 5 306 0.9× 128 0.4× 47 0.6× 14 0.3× 41 1.0× 8 436
Ewa Gogola Netherlands 9 654 1.8× 544 1.8× 98 1.3× 14 0.3× 60 1.5× 11 812

Countries citing papers authored by Anne Catherine Bretz

Since Specialization
Citations

This map shows the geographic impact of Anne Catherine Bretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Catherine Bretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Catherine Bretz more than expected).

Fields of papers citing papers by Anne Catherine Bretz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Catherine Bretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Catherine Bretz. The network helps show where Anne Catherine Bretz may publish in the future.

Co-authorship network of co-authors of Anne Catherine Bretz

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Catherine Bretz. A scholar is included among the top collaborators of Anne Catherine Bretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Catherine Bretz. Anne Catherine Bretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Streubel, Gundula, et al.. (2021). Mode-of-action of HDAC inhibitor resminostat in CTCL. European Journal of Cancer. 156. S39–S40.
2.
Song, Lina, Anne Catherine Bretz, Ivelina Spassova, et al.. (2020). The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells. Journal of Investigative Dermatology. 141(4). 903–912.e4. 37 indexed citations
3.
Bretz, Anne Catherine, et al.. (2019). Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME). Journal for ImmunoTherapy of Cancer. 7(1). 294–294. 61 indexed citations
4.
Jüngerkes, Frank, et al.. (2019). Standardized qc assays and large scale expansion of pluripotent stem cells using an automated closed system.. Cytotherapy. 21(5). S90–S90. 1 indexed citations
5.
Bretz, Anne Catherine, et al.. (2018). Resminostat affects transcriptional regulation of disease-related processes in CTCL. European Journal of Cancer. 101. S2–S2. 1 indexed citations
6.
7.
Bretz, Anne Catherine, Joël P. Charles, Niklas Gremke, et al.. (2016). ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma. Nucleic Acids Research. 44(7). 3204–3218. 19 indexed citations
8.
Wanzel, Michael, Niklas Gremke, Marco Mernberger, et al.. (2016). CRISPR-Cas9-based target validation for p53-reactivating model compounds. European Journal of Cancer. 61. S122–S122. 2 indexed citations
9.
Wanzel, Michael, Niklas Gremke, Rajkumar Savai, et al.. (2015). CRISPR-Cas9–based target validation for p53-reactivating model compounds. Nature Chemical Biology. 12(1). 22–28. 68 indexed citations
10.
Bette, Michael, Anne Catherine Bretz, Chengzhong Cai, et al.. (2014). A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53mut exhibits ATP-binding cassette transporter upregulation and high glutathione levels. Journal of Cancer Research and Clinical Oncology. 140(10). 1689–1704. 30 indexed citations
11.
Bretz, Anne Catherine, et al.. (2011). Targeting p73 in cancer. Cancer Letters. 332(2). 229–236. 33 indexed citations
12.
Schlereth, Katharina, Rasa Beinoravičiūtė-Kellner, Markus Zeitlinger, et al.. (2010). DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis. Molecular Cell. 38(3). 356–368. 87 indexed citations
13.
Schlereth, Katharina, Joël P. Charles, Anne Catherine Bretz, & Thorsten Stiewe. (2010). Life or death. Cell Cycle. 9(20). 4068–4076. 42 indexed citations
14.
Beitzinger, Michaela, Lars Hofmann, Rasa Beinoravičiūtė-Kellner, et al.. (2008). p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth. The EMBO Journal. 27(5). 792–803. 44 indexed citations
15.
Sauer, Markus, Anne Catherine Bretz, Rasa Beinoravičiūtė-Kellner, et al.. (2008). C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity. Nucleic Acids Research. 36(6). 1900–1912. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubert Fleury Breakdown of academic impact, for papers by Joseph A. Wawrzyniak Breakdown of academic impact, for papers by Marco Barazas Breakdown of academic impact, for papers by Kevin T. Nash Breakdown of academic impact, for papers by Joy Hendley Breakdown of academic impact, for papers by Jean‐Claude Ehrhart Breakdown of academic impact, for papers by Miha Pavšič Breakdown of academic impact, for papers by Silke E. Lindner Breakdown of academic impact, for papers by Lynn Meister Breakdown of academic impact, for papers by Ewa Gogola
Rankless by CCL
2026